Assignee
PMV PHARMACEUTICALS INC
US·12 granted patents·13 pending applications·31 citations·filing 2017–2025
Top patents by PatentIndex Score
25 records- 0194US11339141B2Methods and compounds for restoring mutant p53 functionPMV PHARMACEUTICALS INC·Filed 2020·Granted May 24, 2022·4 cites·24 claims
- 0293US11807644B2Methods and compounds for restoring mutant p53 functionPMV PHARMACEUTICALS INC·Filed 2021·Granted Nov 7, 2023·3 cites·21 claims
- 0391US11938124B2Combination therapy for treatment of cancerPMV PHARMACEUTICALS INC·Filed 2021·Granted Mar 26, 2024·2 cites·28 claims
- 0491US10640485B2Methods and compounds for restoring mutant p53 functionPMV PHARMACEUTICALS INC·Filed 2018·Granted May 5, 2020·7 cites·27 claims
- 0590US11963953B2Deuterated compounds for restoring mutant p53 functionPMV PHARMACEUTICALS INC·Filed 2023·Granted Apr 23, 2024·2 cites·33 claims
- 0690US11814373B2Methods and compounds for restoring mutant p53 functionPMV PHARMACEUTICALS INC·Filed 2020·Granted Nov 14, 2023·2 cites·16 claims
- 0790US10138219B2Methods and compounds for restoring mutant p53 functionPMV PHARMACEUTICALS INC·Filed 2017·Granted Nov 27, 2018·11 cites·46 claims
- 0882US12428406B2Methods and compounds for restoring mutant p53 functionPMV PHARMACEUTICALS INC·Filed 2023·Granted Sep 30, 2025·0 cites·20 claims
- 0978US2026098032A1METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTIONPMV PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1075US2022213062A1METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTIONPMV PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1173US2024269126A1Combination therapy for treatment of cancerPMV PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1270US2024043436A1METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTIONPMV PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1368US2024342151A1DEUTERATED COMPOUNDS FOR RESTORING MUTANT p53 FUNCTIONPMV PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1463US2026027097A1METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTIONPMV PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1563US2024100050A1Mdm2 inhibitors and uses thereofPMV PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1663US2024116910A1Heterocycles as WIP1 InhibitorsPMV PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1759US2025319063A1Methods and compounds for restoring mutant p53 functionPMV PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1856US2026053785A1Combination therapy for treatment of cancerPMV PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1955US2021405056A1Methods for detecting mutant p53 functionPMV PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2055US2021403945A1Compositions and methods utilizing genetically-modified animals and cellsPMV PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2154US12570645B2Uses of p53 x-ray co-crystal structuresPMV PHARMACEUTICALS INC·Filed 2021·Granted Mar 10, 2026·0 cites·8 claims
- 2254US12419880B2Companion diagnostic tool for mutant p53 reactivating compoundsPMV PHARMACEUTICALS INC·Filed 2021·Granted Sep 23, 2025·0 cites·16 claims
- 2354US11926632B2Methods and compounds for restoring mutant p53 functionPMV PHARMACEUTICALS INC·Filed 2021·Granted Mar 12, 2024·0 cites·12 claims
- 2454US2023049952A1Methods and compounds for restoring mutant p53 functionPMV PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2553US11731953B2Methods and compounds for restoring mutant p53 functionPMV PHARMACEUTICALS INC·Filed 2021·Granted Aug 22, 2023·0 cites·22 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →